Association of mindfulness with female sexual dysfunction.


Journal

Maturitas
ISSN: 1873-4111
Titre abrégé: Maturitas
Pays: Ireland
ID NLM: 7807333

Informations de publication

Date de publication:
07 2022
Historique:
received: 17 11 2021
revised: 01 02 2022
accepted: 10 02 2022
entrez: 10 6 2022
pubmed: 11 6 2022
medline: 15 6 2022
Statut: ppublish

Résumé

Female sexual dysfunction (FSD) affects women of all ages. It is often a multifactorial problem with a strong psychosocial component. Mindfulness may help alleviate FSD with nonjudgmental, present-moment awareness and decreased emotional reactivity. The goal of this study was to assess the association between dispositional or trait mindfulness and FSD. In this cross-sectional study at a tertiary care women's health clinic, 1718 cisgender women (mean age, 51.9 years) completed the Mindfulness Attention Awareness Scale (MAAS), Female Sexual Function Index (FSFI), and Female Sexual Distress Scale-Revised (FSDS-R). Regression analysis was used to test the associations of mindfulness, sexual function, and sexual distress with univariate and multivariable analyses, adjusting for potential confounders. Within the sample, 57% of women met FSD criteria (FSFI scores ≤26.55 and FSDS-R ≥ 11). On univariate analysis, higher MAAS scores, signifying greater mindfulness, were associated with higher (better) sexual function scores, lower sexual distress scores, and lower odds of FSD. This association persisted on multivariable analysis after adjusting for potential confounders. Higher trait mindfulness was associated with better sexual function, lower sexual distress, and lower likelihood of FSD. Further studies are needed to assess the role of mindfulness in mitigating FSD.

Identifiants

pubmed: 35688491
pii: S0378-5122(22)00043-3
doi: 10.1016/j.maturitas.2022.02.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

27-32

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Richa Sood's husband is the owner/CEO of Global Center for Resiliency and Well-being and The GRIT Institute. Ekta Kapoor has received consultant fees for Astellas Pharmaceuticals, personal fees from CogniMed, personal fees from Med Learning Group, consultant fees and grant support from Mithra Pharmaceuticals, personal fees from PriMed, and consultant fees from Womaness, all of which are outside the scope of the submitted work. All other authors declare that they have no competing interests.

Auteurs

Richa Sood (R)

Menopause and Women's Sexual Health Clinic, Mayo Clinic, Rochester, MN, United States; Mayo Clinic Women's Health, Mayo Clinic, Rochester, MN, United States. Electronic address: sood.richa@mayo.edu.

Carol L Kuhle (CL)

Menopause and Women's Sexual Health Clinic, Mayo Clinic, Rochester, MN, United States; Mayo Clinic Women's Health, Mayo Clinic, Rochester, MN, United States.

Jacqueline M Thielen (JM)

Mayo Clinic Women's Health, Mayo Clinic, Rochester, MN, United States; Division of General Internal Medicine, Mayo Clinic, Jacksonville, FL, United States.

Ekta Kapoor (E)

Menopause and Women's Sexual Health Clinic, Mayo Clinic, Rochester, MN, United States; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN, United States; Mayo Clinic Women's Health, Mayo Clinic, Rochester, MN, United States; Women's Health Research Center, Mayo Clinic, Rochester, MN, United States.

Jennifer A Vencill (JA)

Menopause and Women's Sexual Health Clinic, Mayo Clinic, Rochester, MN, United States; Mayo Clinic Women's Health, Mayo Clinic, Rochester, MN, United States; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States.

Kristin C Mara (KC)

Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, United States.

Stephanie S Faubion (SS)

Mayo Clinic Women's Health, Mayo Clinic, Rochester, MN, United States; Women's Health Research Center, Mayo Clinic, Rochester, MN, United States; Division of General Internal Medicine, Mayo Clinic, Jacksonville, FL, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH